News & Analysis on Clinical Trial Services & Contract Research And Development
Elite Pharmaceuticals has halted trials of its reformulated opioid painkiller SequestOx (naltrexone and oxycodone hydrochloride) after disappointing bioequivalence data from a study testing the drug in combination with a high fat meal.
The data-focused clinical research organization (CRO) Quanticate has upgraded its pharmacovigilance safety database ahead of EudraVigilance’s go-live in November.
Three biosimilar products submitted to the EU for approval have suffered a setback after regulators found 35 GMP deficiencies at Biocon’s fill/finish facility in Bangalore, India.
Q&A
As cancer rates increase in the Asia-Pacific region, and clinical trial capabilities grow in India and China, demand for research is on the rise.
The French government has announced it will make more vaccines mandatory from 2018 onwards.
The preclinical CRO Pharmatest has developed an animal model to clarify the role of human immune cells in bone metastases using Taconic Biosciences’ huNOG model.
IndieBio has teamed up with Science Exchange’s network of more than 2,500 qualified scientific service providers in a strategic partnership that “levels the playing field” for startups.
Researchers at London, UK-based Imperial College are developing a technology to transport drugs directly to the lungs of pulmonary arterial hypertension (PAH) patients.
Newlink Genetics Corporation has expended its indoximod IP portfolio weeks after data suggested the cancer drug may make Provenge and Keytruda more effective.